Global Myotonic Dystrophy Type 1 (DM1) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Myotonic Dystrophy Type 1 (DM1) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Myotonic Dystrophy Type 1 (DM1) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Myotonic Dystrophy Type 1 (DM1) by Country/Region, 2017, 2022 & 2028

2.2 Myotonic Dystrophy Type 1 (DM1) Segment by Type

2.2.1 Exondys

2.2.2 Emflaza

2.2.3 Translarna

2.3 Myotonic Dystrophy Type 1 (DM1) Sales by Type

2.3.1 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)

2.3.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Myotonic Dystrophy Type 1 (DM1) Sale Price by Type (2017-2022)

2.4 Myotonic Dystrophy Type 1 (DM1) Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Home Care

2.5 Myotonic Dystrophy Type 1 (DM1) Sales by Application

2.5.1 Global Myotonic Dystrophy Type 1 (DM1) Sale Market Share by Application (2017-2022)

2.5.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Myotonic Dystrophy Type 1 (DM1) Sale Price by Application (2017-2022)

3 Global Myotonic Dystrophy Type 1 (DM1) by Company

3.1 Global Myotonic Dystrophy Type 1 (DM1) Breakdown Data by Company

3.1.1 Global Myotonic Dystrophy Type 1 (DM1) Annual Sales by Company (2020-2022)

3.1.2 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Company (2020-2022)

3.2 Global Myotonic Dystrophy Type 1 (DM1) Annual Revenue by Company (2020-2022)

3.2.1 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Company (2020-2022)

3.2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Company (2020-2022)

3.3 Global Myotonic Dystrophy Type 1 (DM1) Sale Price by Company

3.4 Key Manufacturers Myotonic Dystrophy Type 1 (DM1) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Location Distribution

3.4.2 Players Myotonic Dystrophy Type 1 (DM1) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Myotonic Dystrophy Type 1 (DM1) by Geographic Region

4.1 World Historic Myotonic Dystrophy Type 1 (DM1) Market Size by Geographic Region (2017-2022)

4.1.1 Global Myotonic Dystrophy Type 1 (DM1) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Myotonic Dystrophy Type 1 (DM1) Annual Revenue by Geographic Region

4.2 World Historic Myotonic Dystrophy Type 1 (DM1) Market Size by Country/Region (2017-2022)

4.2.1 Global Myotonic Dystrophy Type 1 (DM1) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Myotonic Dystrophy Type 1 (DM1) Annual Revenue by Country/Region

4.3 Americas Myotonic Dystrophy Type 1 (DM1) Sales Growth

4.4 APAC Myotonic Dystrophy Type 1 (DM1) Sales Growth

4.5 Europe Myotonic Dystrophy Type 1 (DM1) Sales Growth

4.6 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Growth

5 Americas

5.1 Americas Myotonic Dystrophy Type 1 (DM1) Sales by Country

5.1.1 Americas Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022)

5.1.2 Americas Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022)

5.2 Americas Myotonic Dystrophy Type 1 (DM1) Sales by Type

5.3 Americas Myotonic Dystrophy Type 1 (DM1) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Myotonic Dystrophy Type 1 (DM1) Sales by Region

6.1.1 APAC Myotonic Dystrophy Type 1 (DM1) Sales by Region (2017-2022)

6.1.2 APAC Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2022)

6.2 APAC Myotonic Dystrophy Type 1 (DM1) Sales by Type

6.3 APAC Myotonic Dystrophy Type 1 (DM1) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Myotonic Dystrophy Type 1 (DM1) by Country

7.1.1 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022)

7.1.2 Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022)

7.2 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Type

7.3 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) by Country

8.1.1 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022)

8.2 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Type

8.3 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Myotonic Dystrophy Type 1 (DM1)

10.3 Manufacturing Process Analysis of Myotonic Dystrophy Type 1 (DM1)

10.4 Industry Chain Structure of Myotonic Dystrophy Type 1 (DM1)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Myotonic Dystrophy Type 1 (DM1) Distributors

11.3 Myotonic Dystrophy Type 1 (DM1) Customer

12 World Forecast Review for Myotonic Dystrophy Type 1 (DM1) by Geographic Region

12.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Region

12.1.1 Global Myotonic Dystrophy Type 1 (DM1) Forecast by Region (2023-2028)

12.1.2 Global Myotonic Dystrophy Type 1 (DM1) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Myotonic Dystrophy Type 1 (DM1) Forecast by Type

12.7 Global Myotonic Dystrophy Type 1 (DM1) Forecast by Application

13 Key Players Analysis

13.1 Dyne

13.1.1 Dyne Company Information

13.1.2 Dyne Myotonic Dystrophy Type 1 (DM1) Product Offered

13.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Dyne Main Business Overview

13.1.5 Dyne Latest Developments

13.2 Audentes

13.2.1 Audentes Company Information

13.2.2 Audentes Myotonic Dystrophy Type 1 (DM1) Product Offered

13.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Audentes Main Business Overview

13.2.5 Audentes Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Myotonic Dystrophy Type 1 (DM1) Product Offered

13.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Vertex

13.4.1 Vertex Company Information

13.4.2 Vertex Myotonic Dystrophy Type 1 (DM1) Product Offered

13.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Vertex Main Business Overview

13.4.5 Vertex Latest Developments

13.5 PepGen

13.5.1 PepGen Company Information

13.5.2 PepGen Myotonic Dystrophy Type 1 (DM1) Product Offered

13.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 PepGen Main Business Overview

13.5.5 PepGen Latest Developments

13.6 NeuBase Therapeutics

13.6.1 NeuBase Therapeutics Company Information

13.6.2 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offered

13.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 NeuBase Therapeutics Main Business Overview

13.6.5 NeuBase Therapeutics Latest Developments

13.7 Lupin

13.7.1 Lupin Company Information

13.7.2 Lupin Myotonic Dystrophy Type 1 (DM1) Product Offered

13.7.3 Lupin Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Lupin Main Business Overview

13.7.5 Lupin Latest Developments

13.8 AMO Pharma

13.8.1 AMO Pharma Company Information

13.8.2 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Offered

13.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 AMO Pharma Main Business Overview

13.8.5 AMO Pharma Latest Developments

13.9 Expansion Therapeutics

13.9.1 Expansion Therapeutics Company Information

13.9.2 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offered

13.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Expansion Therapeutics Main Business Overview

13.9.5 Expansion Therapeutics Latest Developments

13.10 Harmony Biosciences

13.10.1 Harmony Biosciences Company Information

13.10.2 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Offered

13.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Harmony Biosciences Main Business Overview

13.10.5 Harmony Biosciences Latest Developments

14 Research Findings and Conclusion

Table 1. Myotonic Dystrophy Type 1 (DM1) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Myotonic Dystrophy Type 1 (DM1) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Exondys

Table 4. Major Players of Emflaza

Table 5. Major Players of Translarna

Table 6. Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)

Table 7. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)

Table 8. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2017-2022) & ($ million)

Table 9. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type (2017-2022)

Table 10. Global Myotonic Dystrophy Type 1 (DM1) Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)

Table 12. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)

Table 13. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2017-2022)

Table 14. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application (2017-2022)

Table 15. Global Myotonic Dystrophy Type 1 (DM1) Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Myotonic Dystrophy Type 1 (DM1) Sales by Company (2020-2022) & (Units)

Table 17. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Company (2020-2022)

Table 18. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Company (2020-2022)

Table 20. Global Myotonic Dystrophy Type 1 (DM1) Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Myotonic Dystrophy Type 1 (DM1) Producing Area Distribution and Sales Area

Table 22. Players Myotonic Dystrophy Type 1 (DM1) Products Offered

Table 23. Myotonic Dystrophy Type 1 (DM1) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Myotonic Dystrophy Type 1 (DM1) Sales by Geographic Region (2017-2022) & (Units)

Table 27. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Geographic Region (2017-2022)

Table 28. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Myotonic Dystrophy Type 1 (DM1) Sales by Country/Region (2017-2022) & (Units)

Table 31. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country/Region (2017-2022)

Table 32. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)

Table 35. Americas Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2022)

Table 36. Americas Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2022)

Table 38. Americas Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)

Table 39. Americas Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)

Table 40. Americas Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)

Table 41. Americas Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)

Table 42. APAC Myotonic Dystrophy Type 1 (DM1) Sales by Region (2017-2022) & (Units)

Table 43. APAC Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2022)

Table 44. APAC Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2017-2022)

Table 46. APAC Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)

Table 47. APAC Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)

Table 48. APAC Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)

Table 49. APAC Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)

Table 50. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)

Table 51. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2022)

Table 52. Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2022)

Table 54. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)

Table 55. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)

Table 56. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)

Table 57. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)

Table 59. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)

Table 63. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)

Table 65. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Myotonic Dystrophy Type 1 (DM1)

Table 67. Key Market Challenges & Risks of Myotonic Dystrophy Type 1 (DM1)

Table 68. Key Industry Trends of Myotonic Dystrophy Type 1 (DM1)

Table 69. Myotonic Dystrophy Type 1 (DM1) Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Myotonic Dystrophy Type 1 (DM1) Distributors List

Table 72. Myotonic Dystrophy Type 1 (DM1) Customer List

Table 73. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Region (2023-2028) & (Units)

Table 74. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Forecast by Region

Table 75. Global Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2023-2028) & (Units)

Table 78. Americas Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Region (2023-2028) & (Units)

Table 80. APAC Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2023-2028) & (Units)

Table 82. Europe Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2023-2028) & (Units)

Table 84. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Type (2023-2028) & (Units)

Table 86. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Application (2023-2028) & (Units)

Table 90. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share Forecast by Application (2023-2028)

Table 93. Dyne Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 94. Dyne Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 95. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Dyne Main Business

Table 97. Dyne Latest Developments

Table 98. Audentes Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 99. Audentes Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 100. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Audentes Main Business

Table 102. Audentes Latest Developments

Table 103. Pfizer Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 104. Pfizer Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 105. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Pfizer Main Business

Table 107. Pfizer Latest Developments

Table 108. Vertex Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 109. Vertex Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 110. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Vertex Main Business

Table 112. Vertex Latest Developments

Table 113. PepGen Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 114. PepGen Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 115. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. PepGen Main Business

Table 117. PepGen Latest Developments

Table 118. NeuBase Therapeutics Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 119. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 120. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. NeuBase Therapeutics Main Business

Table 122. NeuBase Therapeutics Latest Developments

Table 123. Lupin Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 124. Lupin Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 125. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Lupin Main Business

Table 127. Lupin Latest Developments

Table 128. AMO Pharma Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 129. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 130. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. AMO Pharma Main Business

Table 132. AMO Pharma Latest Developments

Table 133. Expansion Therapeutics Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 134. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 135. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Expansion Therapeutics Main Business

Table 137. Expansion Therapeutics Latest Developments

Table 138. Harmony Biosciences Basic Information, Myotonic Dystrophy Type 1 (DM1) Manufacturing Base, Sales Area and Its Competitors

Table 139. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Offered

Table 140. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Harmony Biosciences Main Business

Table 142. Harmony Biosciences Latest Developments

List of Figures

Figure 1. Picture of Myotonic Dystrophy Type 1 (DM1)

Figure 2. Myotonic Dystrophy Type 1 (DM1) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Myotonic Dystrophy Type 1 (DM1) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Exondys

Figure 10. Product Picture of Emflaza

Figure 11. Product Picture of Translarna

Figure 12. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type in 2021

Figure 13. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type (2017-2022)

Figure 14. Myotonic Dystrophy Type 1 (DM1) Consumed in Hospitals

Figure 15. Global Myotonic Dystrophy Type 1 (DM1) Market: Hospitals (2017-2022) & (Units)

Figure 16. Myotonic Dystrophy Type 1 (DM1) Consumed in Clinics

Figure 17. Global Myotonic Dystrophy Type 1 (DM1) Market: Clinics (2017-2022) & (Units)

Figure 18. Myotonic Dystrophy Type 1 (DM1) Consumed in Home Care

Figure 19. Global Myotonic Dystrophy Type 1 (DM1) Market: Home Care (2017-2022) & (Units)

Figure 20. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)

Figure 21. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application in 2021

Figure 22. Myotonic Dystrophy Type 1 (DM1) Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Company in 2021

Figure 24. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Geographic Region in 2021

Figure 26. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2022)

Figure 27. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country/Region in 2021

Figure 28. Americas Myotonic Dystrophy Type 1 (DM1) Sales 2017-2022 (Units)

Figure 29. Americas Myotonic Dystrophy Type 1 (DM1) Revenue 2017-2022 ($ Millions)

Figure 30. APAC Myotonic Dystrophy Type 1 (DM1) Sales 2017-2022 (Units)

Figure 31. APAC Myotonic Dystrophy Type 1 (DM1) Revenue 2017-2022 ($ Millions)

Figure 32. Europe Myotonic Dystrophy Type 1 (DM1) Sales 2017-2022 (Units)

Figure 33. Europe Myotonic Dystrophy Type 1 (DM1) Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales 2017-2022 (Units)

Figure 35. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue 2017-2022 ($ Millions)

Figure 36. Americas Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2021

Figure 37. Americas Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country in 2021

Figure 38. United States Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region in 2021

Figure 43. APAC Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Regions in 2021

Figure 44. China Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2021

Figure 51. Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country in 2021

Figure 52. Germany Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country in 2021

Figure 59. Egypt Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Myotonic Dystrophy Type 1 (DM1) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Myotonic Dystrophy Type 1 (DM1) in 2021

Figure 65. Manufacturing Process Analysis of Myotonic Dystrophy Type 1 (DM1)

Figure 66. Industry Chain Structure of Myotonic Dystrophy Type 1 (DM1)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles